Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation
{{output}}
Background: The aim of the present study was to examine the association between interleukin-2 receptor antagonists (IL-2Ra) and new-onset diabetes after transplantation (NODAT) among renal transplant recipients (RTRs). ... ...
